IONS

Ionis Pharmaceuticals Stock Price

39.59
-1.19 (-2.92%)
Upgrade to Real-Time
Regular Market
39.59

Low
39.17

52 Week Range

High
64.37

Best deals to access real time data!
CHART Trader
Monthly Subscription
for only
$30.66
Canadian Level 1 + USA
Monthly Subscription
for only
$38.05
Small Cap Basic
Monthly Subscription
for only
$33.03
VAT not included
Company Name Stock Ticker Symbol Market Type
Ionis Pharmaceuticals Inc IONS NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-1.19 -2.92% 39.59 15:24:01
Open Price Low Price High Price Close Price Prev Close
40.76 39.17 40.92 40.78
Bid Price Ask Price Spread News
39.58 39.59 0.01 - 1
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
11,611 854,648 $ 39.76 $ 33,981,295 1,283,893 39.17 - 64.37
Last Trade Time Type Quantity Stock Price Currency
15:24:01 10 $ 39.59 USD

Ionis Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 5.54B 139.82M 117.55M $ 1.12B $ -371.69M 2.08 126.00
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Ionis Pharmaceuticals News

Date Time Source News Article
4/19/202107:30GlobeNewswire Inc.Biogen Advances Leading Research in Spinal Muscular Atrophy..
4/13/202106:06Edgar (US Regulatory)Current Report Filing (8-k)
4/08/202107:26Seeking AlphaIonis Pharmaceuticals prices upsized $550M convertible..
4/08/202107:05PR Newswire (US)Ionis prices private placement of convertible senior notes
4/06/202116:36PR Newswire (US)Ionis announces proposed private placement of convertible..
4/06/202108:07Seeking AlphaProgenity and Ionis ink collaboration agreement
4/06/202107:01Edgar (US Regulatory)Current Report Filing (8-k)
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical IONS Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week42.0242.552539.1741.041,275,182-2.43-5.78%
1 Month54.6055.9639.1743.722,094,805-15.01-27.49%
3 Months62.3464.3739.1749.791,276,904-22.75-36.49%
6 Months47.45564.3739.1751.291,171,974-7.87-16.57%
1 Year54.9364.3739.1752.601,002,804-15.34-27.93%
3 Years46.0488.707539.0756.001,056,975-6.45-14.01%
5 Years43.2588.707519.592748.511,292,792-3.66-8.46%

Ionis Pharmaceuticals Description

Ionis Pharmaceuticals is the leading developer of antisense technology to discover and develop novel drugs. Ionis' broad clinical and preclinical pipeline targets a wide variety of diseases, with an emphasis on cardiovascular, metabolic, neurological, and rare diseases. Ionis and partner Biogen brought Spinraza to market in 2016 as a treatment for a rare neuromuscular disorder, spinal muscular atrophy. Ionis subsequently brought two additional drugs to market via its cardiovascular-focused subsidiary Akcea, including ATTR amyloidosis drug Tegsedi (2018) and cardiology drug Waylivra (Europe, 2019).
Your Recent History
NASDAQ
IONS
Ionis Phar..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20210419 19:39:02